Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 8875554)

  • 1. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices.
    So FV; Guthrie N; Chambers AF; Moussa M; Carroll KK
    Nutr Cancer; 1996; 26(2):167-81. PubMed ID: 8875554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of oral carcinogenesis by citrus flavonoids.
    Miller EG; Peacock JJ; Bourland TC; Taylor SE; Wright JM; Patil BS; Miller EG
    Nutr Cancer; 2008; 60(1):69-74. PubMed ID: 18444138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of mammary cancer by citrus flavonoids.
    Guthrie N; Carroll KK
    Adv Exp Med Biol; 1998; 439():227-36. PubMed ID: 9781306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin.
    Verma AK; Johnson JA; Gould MN; Tanner MA
    Cancer Res; 1988 Oct; 48(20):5754-8. PubMed ID: 3139283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice.
    Erlund I; Meririnne E; Alfthan G; Aro A
    J Nutr; 2001 Feb; 131(2):235-41. PubMed ID: 11160539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavanone absorption after naringin, hesperidin, and citrus administration.
    Ameer B; Weintraub RA; Johnson JV; Yost RA; Rouseff RL
    Clin Pharmacol Ther; 1996 Jul; 60(1):34-40. PubMed ID: 8689809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid chromatographic determination of naringin and neohesperidin as a detector of grapefruit juice in orange juice.
    Rouseff RL
    J Assoc Off Anal Chem; 1988; 71(4):798-802. PubMed ID: 3417605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of rat mammary tumorigenesis by concord grape juice constituents.
    Singletary KW; Stansbury MJ; Giusti M; Van Breemen RB; Wallig M; Rimando A
    J Agric Food Chem; 2003 Dec; 51(25):7280-6. PubMed ID: 14640571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purple grape juice inhibits 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation.
    Jung KJ; Wallig MA; Singletary KW
    Cancer Lett; 2006 Feb; 233(2):279-88. PubMed ID: 15878797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice.
    Manach C; Morand C; Gil-Izquierdo A; Bouteloup-Demange C; Rémésy C
    Eur J Clin Nutr; 2003 Feb; 57(2):235-42. PubMed ID: 12571654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice.
    Miniscalco A; Lundahl J; Regårdh CG; Edgar B; Eriksson UG
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1195-9. PubMed ID: 1602384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate.
    el-Bayoumy K; Chae YH; Upadhyaya P; Meschter C; Cohen LA; Reddy BS
    Cancer Res; 1992 May; 52(9):2402-7. PubMed ID: 1568209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction.
    Li P; Callery PS; Gan LS; Balani SK
    Drug Metab Dispos; 2007 Jul; 35(7):1203-8. PubMed ID: 17452418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of different animal and vegetable fats fed before and during carcinogen administration on mammary tumorigenesis, sexual maturation, and endocrine function in rats.
    Sylvester PW; Russell M; Ip MM; Ip C
    Cancer Res; 1986 Feb; 46(2):757-62. PubMed ID: 3940641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice.
    Bailey DG; Dresser GK; Leake BF; Kim RB
    Clin Pharmacol Ther; 2007 Apr; 81(4):495-502. PubMed ID: 17301733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of D,L-2-difluoromethylornithine and indomethacin on mammary tumor promotion in rats fed high n-3 and/or n-6 fat diets.
    Abou-el-Ela SH; Prasse KW; Farrell RL; Carroll RW; Wade AE; Bunce OR
    Cancer Res; 1989 Mar; 49(6):1434-40. PubMed ID: 2538226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
    Sylvester PW; Ip C; Ip MM
    Cancer Res; 1986 Feb; 46(2):763-9. PubMed ID: 3079669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of azoxymethane-induced colon cancer by orange juice.
    Miyagi Y; Om AS; Chee KM; Bennink MR
    Nutr Cancer; 2000; 36(2):224-9. PubMed ID: 10890034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fate of naringin in humans: a key to grapefruit juice-drug interactions?
    Fuhr U; Kummert AL
    Clin Pharmacol Ther; 1995 Oct; 58(4):365-73. PubMed ID: 7586927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the prostaglandin synthetase inhibitor indomethacin on tumorigenesis, tumor proliferation, cell kinetics, and receptor contents of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in Sprague-Dawley rats fed a high- or low-fat diet.
    Noguchi M; Taniya T; Koyasaki N; Kumaki T; Miyazaki I; Mizukami Y
    Cancer Res; 1991 May; 51(10):2683-9. PubMed ID: 1902395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.